Preferences on the uptake and completion of single- or three-dose regimen of benzathine penicillin G injection for the treatment of late syphilis: a discrete-choice experiment
Nang Nge Nge Phoo
A , Richard Norman A , Daniel Vujcich B , Jason J. Ong C D , Laurens Manning E F G , Rochelle Tobin A B , Thel Hla E F G and Jonine Jancey A *
A
B
C
D
E
F
G
Abstract
Notifications of syphilis in Australia have increased since 2011, particularly among gay and bisexual men who have sex with men (GBMSM). Adherence to current late latent syphilis treatment regimen is low-moderate, which is a significant health issue. To address this treatment non-compliance, a single high-dose benzathine benzylpenicillin G regimen has been under clinical trial. This study aimed to determine which attributes of either a three-dose or single-dose benzathine benzylpenicillin G regimen for treating late latent syphilis were preferred, and which attributes were deemed most important by a sample of GBMSM in Australia.
A discrete-choice experiment survey was administered to GBMSM. This included two experiments: (1) treatment Day 1, and (2) completion of a full course. Random parameters logit model and latent class analysis were used to analyse choices of preferred attribute levels, and attributes deemed most important by respondents.
A total of 309 respondents completed the survey, having a mean age of 42.35 (±15.4) years. The choices revealed respondents’ preferred attribute levels that were related to the single high-dose regimen, such as one injection on Day 1, the use of a shorter and thinner needle, a single injection, and a single appointment to complete the treatment course. Respondents preferred a shorter injection time. The pain on treatment Day 1, and the total number of injection(s) and appointment(s) to complete a treatment course were of most concern to respondents.
The GBMSM respondents preferred one injection and one appointment for a full treatment course, which supports efforts to develop a single high-dose benzathine benzylpenicillin G regimen for late latent syphilis treatment.
Keywords: benzathine benzylpenicillin G, discrete-choice experiment, preferences, single-dose regimen, survey, syphilis, treatment, treatment adherence.
References
1 Australian Government Department of Health and Aged Care. List of nationally notifiable diseases. 2024. Available at https://www.health.gov.au/topics/communicable-diseases/nationally-notifiable-diseases/list [accessed 12 May 2024]
2 King J, McManus H, Kwon J, Gray R, McGregor S. HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2023. Sydney: Kirby Institute, UNSW Sydney; 2023. 10.26190/f5ph-f972
3 Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2021. Sydney: Kirby Institute, UNSW Sydney; 2021. Available at https://www.kirby.unsw.edu.au/sites/default/files/documents/Annual-Surveillance-Report-2021_STI-221107.pdf
4 Australian Government Department of Health and Aged Care. National syphilis surveillance quarterly report. 2024. Available at https://www.health.gov.au/resources/collections/national-syphilis-monitoring-reports?language=en [Quarter 4: 1 October−31 December 2023]
8 World Health Organization. WHO guideline on syphilis screening and treatment for pregnant women. 2017. Available at https://apps.who.int/iris/bitstream/handle/10665/259003/9789241550093-eng.pdf
9 Eppes CS, Stafford I, Rac M. Syphilis in pregnancy: an ongoing public health threat. Am J Obstet Gynecol 2022; 227(6): 822-38.
| Crossref | Google Scholar | PubMed |
10 Gupta P, Fairley CK, Chen MY, Bradshaw CS, Fehler G, Plummer EL, et al. Increased syphilis testing and detection of late latent syphilis among women after switching from risk-based to opt-out testing strategy in an urban Australian sexual health clinic: a retrospective observational study. Lancet Reg Health West Pac 2023; 40: 100875.
| Crossref | Google Scholar |
11 Queensland Health. Notifications of syphilis in Queensland 2022 report - Public Health Intelligence Branch. Queensland Health; 2023. Available at https://www.health.qld.gov.au/clinical-practice/guidelines-procedures/sex-health/reports-surveillance
12 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Australian STI management guidelines for use in primary care: Syphilis. 2024. Available at https://sti.guidelines.org.au/sexually-transmissible-infections/syphilis/ [accessed 12 May 2024]
13 Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021; 70(4): 1-187.
| Crossref | Google Scholar |
14 Wu M, Seel M, Britton S, Dean JA, Lazarou M, Safa H, et al. Addressing the crisis of congenital syphilis: key findings from an evaluation of the management of syphilis in pregnancy and the newborn in South-East Queensland. Aust N Z J Obstet Gynaecol 2022; 62(1): 91-7.
| Crossref | Google Scholar | PubMed |
15 Mangone E, Bell J, Khurana R, Taylor MM. Treatment completion with three-dose series of benzathine penicillin among people diagnosed with late latent and unknown duration syphilis, Maricopa County, Arizona. Sex Transm Dis 2023; 50(5): 298-303.
| Crossref | Google Scholar | PubMed |
16 Tobin R, Roberts M, Phoo NNN, Manning L, Norman R, Eadie-Mirams E, et al. Factors influencing adult and adolescent completion of treatment of late syphilis: a mixed methods systematic review. Bull World Health Organ 2025; 103(5): 316-27E.
| Crossref | Google Scholar |
17 Cooper J, Enkel SL, Moodley D, Dobinson H, Andersen E, Kado JH, et al. “Hurts less, lasts longer”; a qualitative study on experiences of young people receiving high-dose subcutaneous injections of benzathine penicillin G to prevent rheumatic heart disease in New Zealand. PLoS ONE 2024; 19(5): e0302493.
| Crossref | Google Scholar |
18 Kado J, Hand R, Henderson R, Wyber R, Salman S, Batty K, et al. Pain in the backside: exploring subcutaneous benzathine penicillin G acceptability. Heart Lung Circ 2019; 28: S54.
| Crossref | Google Scholar |
19 Kado J, Salman S, Hla TK, Enkel S, Henderson R, Hand RM, et al. Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study. Antimicrob Agents Chemother 2023; 67(12): e0096223.
| Crossref | Google Scholar |
20 Australian New Zealand Clinical Trials Registry: Sydney (NSW): NHMRC Clinical Trials Centre, University of Sydney (Australia); 2022 – Identifier ACTRN12622000349741. ‘One injection vs. three’: clinical evaluation of a single, high dose subcutaneous infusion of benzathine penicillin G for treatment of syphilis (SCIP Syphilis). 2022. Available at https://www.anzctr.org.au/TrialSearch.aspx#&&conditionCode=&dateOfRegistrationFrom=&interventionDescription=&interventionCodeOperator=OR&primarySponsorType=&gender=&distance=&postcode=&pageSize=20&ageGroup=&recruitmentCountryOperator=OR&recruitmentRegion=ðicsReview=&countryOfRecruitment=®istry=&searchTxt=ACTRN12622000349741&studyType=&allocationToIntervention=&dateOfRegistrationTo=&recruitmentStatus=&interventionCode=&healthCondition=&healthyVolunteers=&page=1&conditionCategory=&fundingSource=&trialStartDateTo=&trialStartDateFrom=&phase= [cited 1 May 2024].
21 Hla TK, Salman S, Kado J, Moore BR, Manning L. Could late-latent syphilis be treated with a single subcutaneous infusion of long-acting penicillin? Sex Health 2024; 21(2): SH24003.
| Crossref | Google Scholar |
22 Enkel SL, Kado J, Hla TK, Salman S, Bennett J, Anderson A, et al. Qualitative assessment of healthy volunteer experience receiving subcutaneous infusions of high-dose benzathine penicillin G (SCIP) provides insights into design of late phase clinical studies. PLoS ONE 2023; 18(4): e0285037.
| Crossref | Google Scholar |
24 Soekhai V, Whichello C, Levitan B, Veldwijk J, Pinto CA, Donkers B, et al. Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review. Drug Discov Today 2019; 24(7): 1324-31.
| Crossref | Google Scholar | PubMed |
25 Van den Broek-Altenburg E, Atherly A. Using discrete choice experiments to measure preferences for hard to observe choice attributes to inform health policy decisions. Health Econ Rev 2020; 10(1): 18.
| Crossref | Google Scholar |
26 Soekhai V, De Bekker-Grob EW, Ellis AR, Vass CM. Discrete choice experiments in health economics: past, present and future. Pharmacoeconomics 2019; 37(2): 201-26.
| Crossref | Google Scholar |
27 Whitty JA, Lancsar E, Rixon K, Golenko X, Ratcliffe J. A systematic review of stated preference studies reporting public preferences for healthcare priority setting. Patient 2014; 7(4): 365-86.
| Crossref | Google Scholar | PubMed |
28 Norman R, Mulhern B, Lancsar E, Lorgelly P, Ratcliffe J, Street D, et al. The use of a discrete choice experiment including both duration and dead for the development of an EQ-5D-5L value set for Australia. Pharmacoeconomics 2023; 41(4): 427-38.
| Crossref | Google Scholar |
29 Humphrey JM, Naanyu V, MacDonald KR, Wools-Kaloustian K, Zimet GD. Stated-preference research in HIV: a scoping review. PLoS ONE 2019; 14(10): e0224566.
| Crossref | Google Scholar |
30 Sibanda EL, d’Elbée M, Maringwa G, Ruhode N, Tumushime M, Madanhire C, et al. Applying user preferences to optimize the contribution of HIV self-testing to reaching the “first 90” target of UNAIDS Fast-track strategy: results from discrete choice experiments in Zimbabwe. J Int AIDS Soc 2019; 22(1): e25245.
| Crossref | Google Scholar |
31 Eaton S, Biggerstaff D, Petrou S, Osipenko L, Gibbs J, Estcourt CS, et al. Young people’s preferences for the use of emerging technologies for asymptomatic regular chlamydia testing and management: a discrete choice experiment in England. BMJ Open 2019; 9(1): e023663.
| Crossref | Google Scholar |
32 Aung ET, Chow EPF, Fairley CK, Phillips TR, Chen MY, Tran J, et al. Preferences of men who have sex with men for performing anal self-examination for the detection of anal syphilis in Australia: a discrete choice experiment. Lancet Reg Health West Pac 2022; 21: 100401.
| Crossref | Google Scholar |
33 Ong JJ, Lourenco RDA, Street D, Smith K, Jamil MS, Terris-Prestholt F, et al. The preferred qualities of human immunodeficiency virus testing and self-testing among men who have sex with men: a discrete choice experiment. Value Health 2020; 23(7): 870-9.
| Crossref | Google Scholar | PubMed |
34 Miners A, Llewellyn C, King C, Pollard A, Roy A, Gilson R, et al. Designing a brief behaviour change intervention to reduce sexually transmitted infections: a discrete choice experiment. Int J STD AIDS 2019; 29(9): 851-60.
| Crossref | Google Scholar |
35 Rodriguez CA, Mitchell JW. Use of stated preference methods in HIV treatment and prevention research in the United States: a systematic review. AIDS Behav 2023; 27(7): 2328-59.
| Crossref | Google Scholar | PubMed |
36 Pieterse A, Stiggelbout A. What are values, utilities, and preferences? A clarification in the context of decision making in health care, and an exploration of measurement issues. In: Diefenbach M, Miller-Halegoua S, Bowen D (editors). Handbook of Health Decision Science. Springer; 2016. pp. 3–13.
37 Salama J, Lee A, Afshin A. Innovating in healthcare delivery: a systematic review and a preference-based framework of patient and provider needs. BMJ Innov 2019; 5(2–3): 92-100.
| Crossref | Google Scholar |
38 Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. PharmacoEconomics 2008; 26(8): 661-77.
| Crossref | Google Scholar |
39 SurveyEngine. The experiment screens. 2023. Available at https://surveyengine.com/surveyengine-software-documentation/the-editing-phase/edit_experiment_screen/ [accessed 12 May 2024]
40 Janssen EM, Segal JB, Bridges JFP. A framework for instrument development of a choice experiment: an application to type 2 diabetes. Patient 2016; 9(5): 465-79.
| Crossref | Google Scholar | PubMed |
41 Kado J, Salman S, Henderson R, Hand R, Wyber R, Page-Sharp M, et al. Subcutaneous administration of benzathine benzylpenicillin G has favourable pharmacokinetic characteristics for the prevention of rheumatic heart disease compared with intramuscular injection: a randomized, crossover, population pharmacokinetic study in healthy adult volunteers. J Antimicrob Chemother 2020; 75(10): 2951-59.
| Crossref | Google Scholar | PubMed |
42 Kado J, Salman S, Hla T, Enkel S, Henderson R, Hand R, et al. Subcutaneous infusions of high-dose benzathine penicillin G (SCIP) is safe, tolerable and potentially suitable for less frequent dosing for rheumatic heart disease secondary prophylaxis. Heart Lung Circ 2022; 31: S301.
| Crossref | Google Scholar |
43 Vass CM, Davison NJ, Vander Stichele G, Payne K. A picture is worth a thousand words: the role of survey training materials in stated-preference studies. Patient 2020; 13(2): 163-73.
| Crossref | Google Scholar | PubMed |
45 University of New South Wales Sydney. Gay Community Periodic Surveys. University of New South Wales Sydney; 2023. Available at https://www.unsw.edu.au/research/csrh/our-projects/gay-community-periodic-surveys [accessed 12 May 2024]
46 Australian Bureau of Statistics. Sample census household form. 2021. Available at https://www.abs.gov.au/system/files/documents/12486ae64f0f0ea2d056ee6aa54adc34/Sample%202021%20Census%20Household%20Form%20%5B1.1MB%5D.pdf [accessed 12 May 2024]
47 Drennan J. Cognitive interviewing: verbal data in the design and pretesting of questionnaires. J Adv Nurs 2003; 42(1): 57-63.
| Crossref | Google Scholar | PubMed |
48 Charters E. The use of think-aloud methods in qualitative research an introduction to think-aloud methods. Brock Educ 2003; 12(2): 68-82.
| Crossref | Google Scholar |
49 Palmer V, Coe A. A best practice guide to qualitative analysis of research to inform healthcare improvement, re-design, implementation and translation guidance document. New South Wales Government: Agency for Clinical Innovation; 2020. Available at https://aci.health.nsw.gov.au/__data/assets/pdf_file/0006/660867/ACI-qualitative-analysis-of-research.pdf
52 Peh KQ, Kwan YH, Goh H, Ramchandani H, Phang JK, Lim ZY, et al. An adaptable framework for factors contributing to medication adherence: results from a systematic review of 102 conceptual frameworks. J Gen Intern Med 2021; 36(9): 2784-95.
| Crossref | Google Scholar | PubMed |
53 Tuğrul E, Khorshıd L. Effect on pain intensity of injection sites and speed of injection associated with intramuscular penicillin. Int J Nurs Pract 2014; 20(5): 468-74.
| Crossref | Google Scholar | PubMed |
54 Thomas N, Andrews R, Kaur S, Juneja R, Saxena A. Needle temperature and pain perception in the treatment of rheumatic heart disease. Br J Card Nurs 2019; 14(3): 134-8.
| Crossref | Google Scholar |
55 Farhadi A, Esmailzadeh M. Effect of local cold on intensity of pain due to Penicillin Benzathin intramuscular injection. Int J Med Sci 2011; 3(11): 343-5.
| Google Scholar |
56 Estrada V, Santiago E, Cabezas I, Cotano JL, Carrió JC, Fuentes-Ferrer M, et al. Tolerability of IM penicillin G benzathine diluted or not with local anesthetics, or different gauge needles for syphilis treatment: a randomized clinical trial. BMC Infect Dis 2019; 19(1): 883.
| Crossref | Google Scholar |
57 Basak T, Demirtas A, Yorubulut SM. Virtual reality and distraction cards to reduce pain during intramuscular benzathine penicillin injection procedure in adults: a randomized controlled trial. J Adv Nurs 2021; 77(5): 2511-18.
| Crossref | Google Scholar | PubMed |
58 Ancillotti M, Eriksson S, Andersson DI, Godskesen T, Fahlquist JN, Veldwijk J. Preferences regarding antibiotic treatment and the role of antibiotic resistance: a discrete choice experiment. Int J Antimicrob Agents 2020; 56(6): 106198.
| Crossref | Google Scholar | PubMed |
59 Tringale M, Stephen G, Boylan A-M, Heneghan C. Integrating patient values and preferences in healthcare: a systematic review of qualitative evidence. BMJ Open 2022; 12(11): e067268.
| Crossref | Google Scholar |
60 Gluyas H. Patient-centred care: improving healthcare outcomes. Nurs Stand 2015; 30(4): 50-9.
| Crossref | Google Scholar | PubMed |
61 Lambooij MS, Harmsen IA, Veldwijk J, De Melker H, Mollema L, Van Weert YWM, et al. Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared. BMC Med Res Methodol 2015; 15: 19.
| Crossref | Google Scholar |
62 De Bekker-Grob EW, Donkers B, Bliemer MC, Veldwijk J, Swait JD. Can healthcare choice be predicted using stated preference data? Soc Sci Med 2020; 246: 112736.
| Crossref | Google Scholar | PubMed |
